Miriam Provost - Sep 15, 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: VP of US Regulatory & FDA Rel.
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol: TMDX
Transactions as of: Sep 15, 2021
Transactions value $: -$30,718
Form type: 4
Date filed: 9/17/2021, 04:34 PM
Previous filing: Aug 3, 2021
Next filing: Dec 28, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Options Exercise	$90.8K	+5.63K	+82.65%	$16.14^*	12.4K	Sep 15, 2021	Direct
transaction	TMDX	Common Stock	Sale	-$122K	-3.88K	-31.19%	$31.34	8.55K	Sep 15, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-5.63K	-37.5%	$0.00	9.38K	Sep 15, 2021	Common Stock	5.63K	$16.14	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
F2	The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.